BETHESDA, Md. — After six years of relentless advocacy work, David Mitchell was finally on the cusp of defeating his Goliath — the pharmaceutical industry.
He sat at his desk cranking through his inbox on Friday afternoon, while lawmakers debated a bill he had helped push, the biggest prescription drug pricing reform in two decades. He found yet another interview request at the top. This time, it was from Good Morning America.
Mitchell is a cancer patient and former political public relations expert who volunteered to become the face of the opposition to the pharmaceutical industry during Washington’s lengthy debate on drug pricing. He’s worked twelve-hour days recently, straining to get the Democrats’ drug pricing reform package across the finish line.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
